US Stock MarketDetailed Quotes
VINC Vincerx Pharma
- 0.252
- -0.004-1.56%
Close Nov 22 16:00 ET
- 0.253
- +0.001+0.44%
Post 20:01 ET
8.46MMarket Cap-293P/E (TTM)
0.268High0.244Low232.51KVolume0.252Open0.256Pre Close60.06KTurnover0.84%Turnover RatioLossP/E (Static)33.56MShares9.37252wk High0.93P/B6.95MFloat Cap0.24452wk Low--Dividend TTM27.59MShs Float26.750Historical High--Div YieldTTM9.73%Amplitude0.244Historical Low0.258Avg Price1Lot Size
Vincerx Pharma Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 4.00%-6.38M | 54.10%-5.83M | 40.89%-7.74M | 32.13%-40.45M | 41.96%-8.02M | 55.32%-6.65M | 20.08%-12.7M | 12.88%-13.09M | -78.44%-59.6M | -20.29%-13.82M |
| Net income from continuing operations | 12.92%-7.84M | 84.35%-1.81M | 15.16%-12.43M | 36.24%-40.16M | 56.04%-4.95M | 46.64%-9.01M | 37.30%-11.55M | 10.80%-14.65M | -60.24%-62.98M | -73.98%-11.26M |
| Operating gains losses | 395.54%331K | -4,560.17%-5.26M | 29,011.11%5.2M | 100.75%47K | 90.32%59K | -241.77%-112K | 109.82%118K | 99.65%-18K | 73.02%-6.3M | 100.28%31K |
| Depreciation and amortization | 8.27%275K | 8.43%270K | 71.43%264K | -2.56%915K | 7.05%258K | 7.63%254K | 7.33%249K | -33.04%154K | 176.18%939K | -29.74%241K |
| Change In working capital | -126.78%-451K | 105.14%125K | -448.27%-1.31M | -310.88%-4.19M | -119.31%-3.82M | 411.28%1.68M | -1,814.08%-2.43M | -66.49%375K | -118.19%-1.02M | -13,484.62%-1.74M |
| -Change in receivables | ---- | ---- | 52.01%-131K | 64.00%328K | -95.50%9K | ---- | ---- | ---273K | --200K | --200K |
| -Change in prepaid assets | -83.39%350K | 393.60%596K | 14.85%-625K | 138.89%1.23M | 102.61%58K | 742.80%2.11M | -551.11%-203K | 40.52%-734K | -403.36%-3.16M | -1,368.00%-2.22M |
| -Change in payables and accrued expense | -18.88%-277K | 95.49%-77K | -113.70%-211K | -397.93%-3.74M | -292.47%-3.34M | 61.87%-233K | -14,325.00%-1.71M | -43.03%1.54M | -79.87%1.25M | -388.51%-850K |
| -Change in other current assets | 8.00%-230K | 55.99%-239K | ---56K | -178.50%-1.08M | -120.87%-284K | ---250K | -341.33%-543K | --0 | 187.33%1.37M | 1,196.19%1.36M |
| -Change in other current liabilities | -13.51%-294K | -12.60%-286K | -79.11%-283K | -26.56%-934K | -13.36%-263K | -12.61%-259K | -81.43%-254K | -16.18%-158K | -720.00%-738K | -149.46%-232K |
| -Change in other working capital | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --50K | --0 |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 4.00%-6.38M | 54.10%-5.83M | 40.89%-7.74M | 32.13%-40.45M | 41.96%-8.02M | 55.32%-6.65M | 20.08%-12.7M | 12.88%-13.09M | -78.44%-59.6M | -20.29%-13.82M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -90.88%1.37M | -156.32%-8.34M | 0 | 202.27%41.5M | 128.21%5.75M | 174.58%15.06M | 14.8M | 5.89M | -671.74%-40.58M | -254,687.50%-20.38M |
| Net investment purchase and sale | -90.88%1.37M | -156.32%-8.34M | --0 | 202.27%41.5M | 128.21%5.75M | 174.58%15.06M | --14.8M | --5.89M | ---40.58M | ---20.38M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -90.88%1.37M | -156.32%-8.34M | --0 | 202.27%41.5M | 128.21%5.75M | 174.58%15.06M | --14.8M | --5.89M | -671.74%-40.58M | -254,687.50%-20.38M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 0 | 18,181.72%17M | 66.67%5K | -59.29%114K | -52.63%18K | 0 | -61.57%93K | 3K | -99.68%280K | -86.57%38K |
| Net common stock issuance | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Proceeds from stock option exercised by employees | --0 | -4.30%89K | 66.67%5K | -59.29%114K | -52.63%18K | --0 | -61.57%93K | --3K | -99.32%280K | -89.17%38K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | --0 | 18,181.72%17M | 66.67%5K | -59.29%114K | -52.63%18K | --0 | -61.57%93K | --3K | -99.68%280K | -86.57%38K |
| Net cash flow | ||||||||||
| Beginning cash position | 18.61%8.01M | 13.88%5.19M | 9.55%12.85M | -89.48%11.73M | -66.97%15.15M | -91.66%6.75M | -95.28%4.56M | -89.48%11.73M | 80.55%111.56M | -62.65%45.87M |
| Current changes in cash | -159.47%-5.01M | 28.95%2.84M | -7.36%-7.73M | 101.16%1.16M | 93.41%-2.25M | 124.00%8.42M | 114.06%2.2M | 52.06%-7.2M | -300.63%-99.9M | -204.72%-34.16M |
| Effect of exchange rate changes | 258.82%27K | -140.00%-24K | 140.00%72K | -156.34%-40K | -259.26%-43K | -213.33%-17K | -183.33%-10K | 76.47%30K | 438.10%71K | 228.57%27K |
| End cash Position | -80.02%3.03M | 18.61%8.01M | 13.88%5.19M | 9.55%12.85M | 9.55%12.85M | -66.97%15.15M | -91.66%6.75M | -95.28%4.56M | -89.48%11.73M | -89.48%11.73M |
| Free cash flow | 4.00%-6.38M | 54.10%-5.83M | 40.89%-7.74M | 32.13%-40.45M | 41.96%-8.02M | 55.32%-6.65M | 20.08%-12.7M | 12.88%-13.09M | -54.17%-59.6M | -20.21%-13.82M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data